Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
and
Drug Reactions
BY P.MWANZAWA
FEB 2015
1
SUB TOPICS
I.
II.
I.
II.
DRUG DOSING
Therapeutic window, Minimum effective
concentration (MEC) & minimum toxic
concentration (MTC)
Loading dose, maintenance doses,
individualizing dosage
Kinds of drug dosages
Therapeutic drug monitoring
Calculation of doses
3
MEC ,MTC
Minimum effective concentration (MEC)
its the lowest drug concentration that can
cause therapeutic effects.
Minimum toxic concentration (MTC) its
the lowest drug concentration a which toxic
effects begin to appear.
Therapeutic window / index is the range
between MEC & MTC.
4
DOSING SCHEDULES
How to dose a drug will depend on desirable
& achievable drug effects; therapeutic index,
drug half life etc. The following are
considered in designing a dosage regimen: Target Level is a set desired steady state
concentration in the plasma which is within
the therapeutic window / range. The dose
adjusted to achieve this target level. This
mode is applied for drug with a small
therapeutic index or whose effects are
difficult to measure.
5
10
11
12
13
14
17
ADVERSE DRUG
REACTIONS
(ADRs)
18
To Cover
Definitions
Introduction
Classification of
ADRs
ADRs predisposing
factors
Mechanisms of
ADRs
Ways to minimise
ADRs
Drug interactions
Allergies definition,
types, manifestation,
treatment.
Diagnosis
19
Side effects
20
Definitions
Toxicity
Secondary effects
21
Introduction
ADRs cause illnesses needing urgent
treatment to prevent death.
Distinguishing between natural
progression of the disease and an ADR
is always challenging so good recording
is necessary to predict ADRs
Pharmacovigilance is the principle of
collecting data on ADRs done either
during clinical trials or normal community
drug use. ( An important role for
pharmacy personnel)
22
Classification of ADRs
Type A (Augmented) reactions occur in all who
receive a high dose as are dose related e.g.
hypoglycemia, hypotension. Are easily controlled.
Type B ( Bizarre) reactions occur only in some
people as are not part of normal pharmacological
effects nor dose related. Patient interactions with drug
due to inherited abnormalities e.g. drug allergies.
Type C (Chronic) reactions due to long term
exposure e.g. analgesic nephropathy.
Type D (Delayed) effects manifests long after drug
use and may be due to short or long term drug use.
E.g. teratogenic
Type E (Ending of use) reactions due to abruptly
23
stopping long term therapy e.g. steroids
Conclusion
When a suspected ADR has occurred, its
helpful to determine if its definitively,
probably or possibly due to the drug.
Issues to assess include Patient history
including other drugs taken eg OTCs,
herbals & Time of occurrence or previous
such effects.
Delayed ADRs are hard to discover &
confirm.
Re-challenge can confirm but its dangerous.
Though ADRs are inevitable, its the
pharmacy personnels role to minimize them26
DRUG
INTERACTIONS
27
INTRODUCTION
It may be desired or undesired, beneficial
of harmful. It may result in antagonism or
synergism.
drug-drug interactions two drugs taken
concomitantly interact. E.g. naloxone as
morphine antidote (beneficial).
Interaction can occur at different stages,
outside the body, pharmacokinetically
(ADME) or pharmacodynamically (at
receptors or body systems)
28
Drug-drug interactions
Drug-food interactions
Drug-receptor interactions
Drug-enzyme interactions
31
ALLERGIES
32
ALLERGIES
Definition:- an allergy is stimulation of an
immune response that is harmful. It oftenly
stimulates the inflammatory process.
Chief target organs for allergies are skin,
respiratory tract, blood & blood vessels.
Cross-allergy means that a patient reacts to
all drugs in that chemical group eg
penicillins
33
34
35
Allergy Diagnosis
Re-challenge is the best confirmatory test
but is not clinically justfied.
Patch skin test
Skin prick test
Antibodies detection.
NB: Drug allergy once occurred may not be
permanent, but its best for the patient to
avoid that drug.
37
INDUCERS
Rifampicin
Carbamazepine
Phenobarbitone
Nevirapine
Tobacco, smoke
Phenytoin
INHIBITORS
Ciprofloxacin
PIs e.g. ritonavir
Cimetidine
Ketoconazole
Isoniazid
Erythromycin
38